Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Stanford University
- Karolinska Institutet (KI)
- Rutgers University
- NEW YORK UNIVERSITY ABU DHABI
- University of Minnesota
- University of North Carolina at Chapel Hill
- Loyola University
- St Jude Children's Research Hospital
- Technical University of Munich
- The University of Arizona
- University of Kentucky
- University of Oxford
- VIB
- Adam Mickiewicz University, Poznań
- Baylor College of Medicine
- EPFL
- East Carolina University
- FAPESP - São Paulo Research Foundation
- Icahn School of Medicine, CABCT
- Indiana University
- Institut Pasteur
- International Institute of Molecular and Cell Biology in Warsaw
- Josep Carreras Leukaemia Research Institute (IJC)
- KTH Royal Institute of Technology
- Luxembourg Institute of Health (LIH)
- National Institute of Research and Innovation
- Naturalis
- Northeastern University
- Research Center for Molecular Medicine (CeMM), ÖAW
- SUNY University at Buffalo
- SciLifeLab
- THE UNIVERSITY OF HONG KONG
- The Ohio State University
- The University of South Dakota
- UNIVERSITY OF HELSINKI
- Universidade Católica Portuguesa
- University Hospital Magdeburg
- University of Bern
- University of California Irvine
- University of California Los Angeles
- University of California, Los Angeles
- University of Cambridge;
- University of Kansas Medical Center
- University of Maryland, Baltimore
- University of Nebraska Medical Center
- University of Nevada Las Vegas
- University of Pennsylvania
- University of Southern California
- University of Southern California - Center for Craniofacial Molecular Biology
- Utrecht University
- Yale University
- 41 more »
- « less
-
Field
-
submit manuscripts and research grants. The overall focus of this post-doctoral research position is the development of self renewable human induced pluripotent stem cell (iPSC)-based therapies
-
explores genetic causes of neurological disorders and aim to develop therapies for these conditions with a high complementary approach, ranging from stem cell modelling to functional genomic. Information
-
) mediate differentiation of induced pluripotent stem cells into cardiovascular lineages, and 2) biomaterials that mediate transdifferentiation of somatic cells into cardiovascular lineage. In particular, we
-
peripheral blood stem cell transplantation and tumor models. Studies may also include use of human cells and humanized NSG mouse models. Ongoing research includes novel approaches in activating anti-tumor
-
system (CNS). We aim to uncover the principles of cell fate regulation during development and repurpose them for regeneration. We use a multidisciplinary approach that involves glial and stem cell biology
-
culture of mouse oocytes and embryos; experience with isolation and culture of embryonic stem cells; experience with immunofluorescence and confocal microscopy; experience with molecular cloning and next
-
differentiation of pluripotent stem cells into retinal cells and tissues. The work will specifically employ scalable culture modalities and bioreactors. This work will be undertaken in close collaboration with
-
/PhD degree with a focus on Metabolism, Mouse Models systems, Human stem cell systems, Biochemical and Molecular Tools, Epigenetics, Genetics, Genomics, Biology, Bioinformatics, Machine Learning, or a
-
NYU Abu Dhabi invites applications for a Post-Doctoral Associate position that advances the frontiers of developmental biology and disease modeling. The laboratory integrates stem-cell biology
-
, organogenesis, stem cells and regenerative medicine. Our studies seek to define molecular mechanisms governing both normal and abnormal craniofacial development, providing scientific rationales for future